http://articles.mercola.com/sites/articles/archive/2003/08/02/off-label.aspxA former employee of one of the nation’s largest pharmaceutical companies filed a lawsuit alleging the company, Warner-Lambert, distorted information to market a drug for off-label uses. The drug, neurontin, which is FDA approved only to help controlenCommunityServer 2008.5 SP1 (Build: 31106.3070)http://articles.mercola.com/sites/articles/archive/2003/08/02/off-label.aspx#36793Tue, 20 Jan 2009 13:59:51 GMT24451277-a5aa-4add-96dc-64081bfd86fa:36793DeborahSue<p>Eli Lilly was fined 2x in the last six months for FDA violations in their marketing. &nbsp;Recently, 1.5 Billion, with 18% of that going to the 6 whistleblower reps for exposing the violation. &nbsp;I am so glad that I am not promoting Zyprexa. &nbsp;The side effects (hyperlipidemia, weight gain, high glucose levels; metabolic syndrome) were addressed with marketing materials to tell the doctor, &quot;you can manage the side effects.&quot; &nbsp;It is grossly wrong to have reps sell products with pressure to produce sales with those side effects. &nbsp;Diseases such as schizophrenia do require serious medication, but as a rep I can say that selling a product to doctors who see patients with milder mental diseases should be disallowed.</p> <img src="http://articles.mercola.com/aggbug.aspx?PostID=36793" width="1" height="1">